[聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎患者引起的皮肤反应]
[Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
作者信息
Enjoji Munechika, Dainichi Teruki, Gondo Hisaki, Urabe Kazunori
机构信息
Department of Hepatology and Pancreatology, Kyushu University Hospital.
出版信息
Fukuoka Igaku Zasshi. 2007 Sep;98(9):353-6.
A 67 years old woman with chronic hepatitis C was treated with pegylated-interferon plus ribavirin combination therapy. Three weeks after starting the therapy, severe cutaneous adverse reaction occurred on her. Specific treatment successfully suppressed the symptom and pegylated-interferon plus ribavirin combination therapy was completely done. Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy was reviewed.
一名67岁的慢性丙型肝炎女性接受了聚乙二醇干扰素联合利巴韦林的联合治疗。治疗开始三周后，她出现了严重的皮肤不良反应。特异性治疗成功抑制了症状，聚乙二醇干扰素联合利巴韦林的联合治疗得以完整完成。对聚乙二醇干扰素联合利巴韦林联合治疗引起的皮肤反应进行了综述。
Zotero 插件